Active Pharmaceutical Ingredient (API)

Mavacamten

Cardiac Myosin Inhibitor

Targeted therapy for obstructive hypertrophic cardiomyopathy (HCM). It reduces the number of myosin-actin cross-bridges to relieve outflow tract obstruction.
Technical Profile
Reference Code
Crd947
CAS Number
1642288-49-4
Chemical Class
N/A
Therapeutic Class
N/A

Verified Brands

Medicines containing Mavacamten as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.